AVID BIOSERVICES INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: Catherine J. Mackey, PhD

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Catherine J. Mackey, Ph.D.”): 39,063,517 for, 3,388,470 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 13,852,143 for, 605,792 withheld, 330 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Esther M. Alegria, PhD

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Esther M. Alegria, Ph.D.”): 39,065,262 for, 3,386,725 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 13,845,977 for, 611,958 withheld, 330 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Gregory P. Sargen

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Gregory P. Sargen”): 38,981,723 for, 3,470,264 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 13,852,143 for, 605,792 withheld, 330 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Jeanne A. Thoma

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 40,348,375 for, 2,103,612 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 14,422,120 for, 36,145 withheld.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Joseph Carleone, PhD

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Joseph Carleone, Ph.D.”): 40,102,583 for, 2,349,404 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 14,422,120 for, 36,145 withheld.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Nicholas S. Green

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Nicholas S. Green”): 41,729,893 for, 722,094 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 14,458,265 for.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Richard B. Hancock

AVID BIOSERVICES INC.’s own tally for this item (“Elect Director: Richard B. Hancock”): 38,727,239 for, 3,724,748 withheld, per its Form 8-K filed October 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “2 Proposal No. 1: Election of Directors The Company's stockholders elected each of the seven nominees named below to serve on the Company's Board of Directors until the Company's 2025 Annual Meeting of Stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 13,774,893 for, 683,042 withheld, 330 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: To approve the adoption of the Agreement and Plan of Merger, dated November 6, 2024 (the "Merger Agreement"), by and among Avid Bioservices, Inc., a Delaware corporation ("Avid"), Space Finco, Inc., a Delaware corporation ("Parent"), and Space Mergerco, Inc., a Delaware corporation and a direct wholly owned Subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Avid, and as a result of which the separate corporate existence of Merger Sub will cease, and Avid will continue as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"), and approve the Merger (the "Merger Agreement Proposal").

The 35 asset managers below reported 6,337,636 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

Description as filed by funds: To approve the adoption of the Agreement and Plan of Merger, dated 11/6/24 (the "Merger Agreement"), by and among Avid Bioservices, Inc., a Delaware corporation ("Avid"), Space Finco, Inc., a Delaware corporation ("Parent"), and Space Mergerco, Inc., a Delaware corporation and a direct wholly owned Subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Avid, and Avid will continue as the surviving corporation (the "Merger"), and approve the Merger (the "Merger Agreement Proposal").

The 27 asset managers below reported 8,403,395 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

Description as filed by funds: To approve the adjournment of the special meeting of Avid stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the Merger Agreement Proposal if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting.

The 60 asset managers below reported 13,835,757 for, 905,273 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Description as filed by funds: To approve an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder.

AVID BIOSERVICES INC.’s own tally for this item (“4. To Approve an Amendment to the Company's 2018 Omnibus Incentive Plan”): 39,422,442 for, 2,834,763 against — passed, per its Form 8-K filed October 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 4: To Approve an Amendment to the Company's 2018 Omnibus Incentive Plan The Company's stockholders approved an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares available for grant thereunder by 3,800,000.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 57 managers: 14,289,793 for, 168,425 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 3 managers: 2,156,940 for.

Description as filed by funds: To approve an amendment to the Company's 2010 Employee Stock Purchase Plan to remove the expiration date.

AVID BIOSERVICES INC.’s own tally for this item (“5. To Approve an Amendment to the Company's 2010 Employee Stock Purchase Plan”): 41,785,365 for, 472,242 against — passed, per its Form 8-K filed October 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 5: To Approve an Amendment to the Company's 2010 Employee Stock Purchase Plan The Company's stockholders approved an amendment to the Company's 2010 Employee Stock Purchase Plan to remove its automatic termination provision.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 14,458,515 for.

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

Description as filed by funds: To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement.

AVID BIOSERVICES INC.’s own tally for this item (“3. To Approve, on an Advisory Basis, the Compensation of the Named Executive Officers”): 39,680,899 for, 2,510,504 against — passed, per its Form 8-K filed October 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3: To Approve, on an Advisory Basis, the Compensation of the Named Executive Officers The Company's stockholders approved, on an advisory basis, a non-binding resolution approving the compensation of the Company's named executive officers as disclosed in the Company's Definitive Proxy …”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 58 managers: 14,422,120 for, 36,145 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 165 managers: 27,265,642 for, 1,547,889 against, 168,577 abstained, 45 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To approve, on an advisory (non- binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contentemplated by the Merger Agreement.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 26 managers: 5,647,176 for, 2,756,218 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 92 managers: 10,797,074 for, 7,168,636 against, 29,049 abstained, 49 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 35 managers: 5,425,194 for, 893,645 against, 18,797 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 89 managers: 8,238,123 for, 2,049,429 against, 18,797 abstained. Showing the 25 largest; see all in the interactive database.

The 3 asset managers below reported 332,273 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2025.

AVID BIOSERVICES INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 49,045,821 for, 1,725,042 against — passed, per its Form 8-K filed October 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2: Ratification of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2025.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 14,428,286 for, 29,979 against.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.